Joshi J, Xu B, Rubart M, Chang Y, Bao X, Chaliki H, et al. Optogenetic Control of Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Live Mice: A Proof-of-Concept Study. Cells. 2022;11: pubmed publisher

Zhao M, Nakada Y, Wei Y, Bian W, Chu Y, Borovjagin A, et al. Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction. Circulation. 2021;144:210-228 pubmed publisher

Muller A, Dickmanns A, Resch C, Schakel K, Hailfinger S, Dobbelstein M, et al. The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. J Clin Invest. 2020;: pubmed publisher

Chang Y, Hellwarth P, Randolph L, Sun Y, Xing Y, Zhu W, et al. Fluorescent indicators for continuous and lineage-specific reporting of cell-cycle phases in human pluripotent stem cells. Biotechnol Bioeng. 2020;117:2177-2186 pubmed publisher

Potapova T, Seidel C, Box A, Rancati G, Li R. Transcriptome analysis of tetraploid cells identifies cyclin D2 as a facilitator of adaptation to genome doubling in the presence of p53. Mol Biol Cell. 2016;27:3065-3084 pubmed

Baker G, Landis M, Hinds P. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation. Cell Cycle. 2005;4:330-8 pubmed